ADSTEM Inj. (Adult human mesenchymal stem cells)

BIOLOGICAL2 trials

Sponsors

EHL Bio Co., Ltd., University Hospital of North Norway

Conditions

Atopic DermatitisOsteoarthritis Knee

Phase 1

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis

CompletedNCT02888704

EHL Bio Co., Ltd.Atopic Dermatitis

Start: 2016-07-31End: 2017-12-31Updated: 2017-12-22

Phase 2

Orthobiologic Treatment for Knee Osteoarthritis

Enrolling by invitationNCT06893250

University Hospital of North NorwayOsteoarthritis Knee

Start: 2024-09-23End: 2027-12-01Target: 160Updated: 2026-06-15